Shionogi & Co., Ltd. (TYO:4507)

Market Cap	2.74T +46.0%
Revenue (ttm)	465.38B +1.9%
Net Income	194.82B +15.5%
EPS	228.94 +15.7%
Shares Out	850.98M
PE Ratio	14.05
Forward PE	13.19
Dividend	66.00 (2.08%)
Ex-Dividend Date	Mar 30, 2026

Volume	1,550,100
Average Volume	3,439,860
Open	3,287.00
Previous Close	3,217.00
Day's Range	3,240.00 - 3,325.00
52-Week Range	2,100.00 - 3,323.00
Beta	-0.08
RSI	73.60
Earnings Date	Jan 30, 2026

About Shionogi &

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1878
• Employees: 4,955
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4507

Financial Performance

In fiscal year 2025, Shionogi &'s revenue was 438.27 billion, an increase of 0.73% compared to the previous year's 435.08 billion. Earnings were 170.44 billion, an increase of 5.19%.